Riskpilot← Back to searchSign inGet full accessVILECON ApS
APSActiveCVR 33498969Baldersbuen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20111 employees
Revenue 2024
DKK 2K
-73% vs 2023
EBITDA margin
100.0%
-73% vs 2023
Equity ratio
75.2%
Financial strength
Net profit 2024
DKK 2K
-74% vs 2023
| Revenue | DKK 2K | -73% |
| EBITDA | DKK 2K | -73% |
| Net profit | DKK 2K | -74% |
| Total assets | DKK 42K | -64% |
| Equity | DKK 32K | +5% |
| Employees | 1 | — |
Legal name
VILECON ApS
CVR number
33498969
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
14. februar 2011
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med udvikling og salg af medicinsk udstyr samt hermed beslægtet virksomhed.
Address
Baldersbuen 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 928 | 1.098 | 814 | 685 | 155 | -0 | -8 | -7 | -7 | -7 | -7 | 8 | 2 |
| Staff expenses | -726 | -767 | -736 | -736 | -122 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 202 | 332 | 78 | -51 | 33 | -0 | -8 | -7 | -7 | -7 | -7 | 8 | 2 |
| Depreciation & amort. | -17 | -19 | -14 | -11 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 184 | 312 | 64 | -62 | 33 | -0 | -8 | -7 | -7 | -7 | -7 | 8 | 2 |
| Net financials | -40 | -49 | -0 | 11 | 3 | 3 | 1 | 1 | 0 | 0 | -0 | 0 | 0 |
| Profit before tax | 144 | 263 | 63 | -51 | 36 | 2 | -7 | -6 | -7 | -7 | -7 | 8 | 2 |
| Tax | 36 | 65 | 11 | -5 | 10 | 1 | -2 | -1 | -2 | -2 | 0 | 2 | 1 |
| Net profit | 108 | 197 | 53 | -47 | 26 | 2 | -6 | -4 | -5 | -5 | -7 | 6 | 2 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 326 | 1.142 | 564 | 378 | 100 | 58 | 52 | 48 | 42 | 37 | 30 | 119 | 42 |
| Equity | 145 | 192 | 245 | 198 | 76 | 52 | 46 | 42 | 36 | 31 | 24 | 30 | 32 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 174 | 947 | 319 | 180 | 24 | 6 | 6 | 6 | 6 | 6 | 6 | 89 | 11 |
| Total debt | 174 | 947 | 319 | 180 | 24 | 6 | 6 | 6 | 6 | 6 | 6 | 89 | 11 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20122024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20122024
Net profit margin
75.3%
This company
8.1%
Market median
+830% vs market
20122024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20122024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Management | Management | 2011 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SPT Vilecon A/S | Company | 100.0% | 100.0% | 2023 |
ENDERSEN HOLDING ApS | Company | 10.0% | 10.0% | 2012 |
SCANDINAVIAN PLASTIC TECHNOLOGY ApS | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T&W Medical A/S
VILECON ApS Board members of VILECON ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjarne Andersen | Management | 0 companies |